News Transactions under Novozymes’ stock buyback program Staff February 15, 2021 Please read the full announcement in the attached PDF Attachment 2021_07_Stock_Buybackprogram Continue Reading Previous Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatientsNext How the Rise in Geriatric Population is Driving Growth of Knee Hyaluronic Acid Injections Market: Future Market Insights Report Analyzes More Stories Healthcare Hospitals Medicaid News CRISP Shared Services Announced as Implementation Center Awardee Under $255M National Public Health Data Modernization Program Staff July 11, 2024 News Pharmaceutical Promising Data on Transdermal Obesity Formulations Announced by Skinvisible Staff July 11, 2024 EHR Healthcare Medicare News Netsmart TheraOffice® Achieves ONC Certification for Enhanced Physical Therapy EHR and Practice Management Staff July 11, 2024
